PF-06282999

N/A

Report date: 2023/10/08 17:31:11

NME

Base Information

Drug NamePF-06282999

Drug Alias NamePF-6282999PF06282999PF-06282999

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMyeloperoxidase inhibitors

TargetsMyeloperoxidase

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A